# Mark Vishnepolsky, M.D. – FDA Inspection, Jun 9, 2026

Source: https://www.keypedia.com/records/fda_inspections/mark-vishnepolsky-md/953df0ff-ebd8-4f17-a25c-b17bdf7eec01
Source feed: FDA_Inspections

> FDA inspection 1321240 of Mark Vishnepolsky, M.D., June 09, 2026. 3 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1321240
- Company Name: Mark Vishnepolsky, M.D.
- Inspection Date: 2026-06-09
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 3

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/andra-lepnis/38811302-3d96-427a-955d-c4c42de05a7c)
- [Investigator](https://www.keypedia.com/people/lan-t-tran/ab9c1008-c03f-425f-ac3c-a569d3e5037c)

Company: https://www.keypedia.com/companies/mark-vishnepolsky-md/50389205-3983-42ba-a53d-031fed73f0da

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df
